Eng-Moriarty Mabel MD Syracuse, NY - 13208

Eng-Moriarty Mabel MD is categorized under Physical Medicine, Physician/Surgeon in Syracuse, NY and active since 2011.

Eng-Moriarty Mabel MD was established in 2011, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Physical Medicine, Physician/Surgeon business, which does work in the B2C market, and is classified as a Physical Medicine, Physician/Surgeon, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Mabel Eng-Moriarty at the company’s single location by writing to 516 Prospect Avenue, Syracuse, New York NY 13208 or by phoning (315) 703-5200. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Eng-Moriarty Mabel MD
Contact Person: Mabel Eng-Moriarty
Address: 516 Prospect Avenue, Syracuse, New York 13208
Phone Number: (315) 703-5200
Annual Revenue (USD): $500.000 to $999.999
Founded: 2011
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Physical Medicine, Physician/Surgeon
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Eng-Moriarty Mabel MD was started in 2011 to provide professional Physical Medicine, Physician/Surgeon under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Mabel Eng-Moriarty for inquiries that concern Eng-Moriarty Mabel MD by calling the company number (315) 703-5200, as your correspondence is most welcome. Additionally, the physical location of the single location of Eng-Moriarty Mabel MD can be found at the coordinates 43.05894,-76.15178 as well as the street address 516 Prospect Avenue in Syracuse, New York 13208.

For its online presence, you may visit Eng-Moriarty Mabel MD’s website at and engage with its social media outlets through on Twitter and on Facebook.